These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25110413)

  • 1. Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.
    Muc-Wierzgoń M; Nowakowska-Zajdel E; Dzięgielewska-Gęsiak S; Kokot T; Klakla K; Fatyga E; Grochowska-Niedworok E; Waniczek D; Wierzgoń J
    World J Gastroenterol; 2014 Aug; 20(29):9759-74. PubMed ID: 25110413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.
    Nimptsch K; Pischon T
    Recent Results Cancer Res; 2016; 208():199-217. PubMed ID: 27909909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
    Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
    Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid levels in serum and cancerous tissues of colorectal cancer patients.
    Zhang X; Zhao XW; Liu DB; Han CZ; Du LL; Jing JX; Wang Y
    World J Gastroenterol; 2014 Jul; 20(26):8646-52. PubMed ID: 25024621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.
    Davies M; Gupta S; Goldspink G; Winslet M
    Int J Colorectal Dis; 2006 Apr; 21(3):201-8. PubMed ID: 15959790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.
    Kasprzak A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Obesity and colorectal cancer].
    Na SY; Myung SJ
    Korean J Gastroenterol; 2012 Jan; 59(1):16-26. PubMed ID: 22289950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and colorectal cancer.
    Aleksandrova K; Nimptsch K; Pischon T
    Front Biosci (Elite Ed); 2013 Jan; 5(1):61-77. PubMed ID: 23276970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing abilities of different lipid measures in diagnosis of insulin resistance: a Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) study.
    Esteghamati A; Zandieh A; Zandieh B; Khalilzadeh O; Esteghamati S; Meysamie A; Nakhjavani M
    Metab Syndr Relat Disord; 2012 Feb; 10(1):63-9. PubMed ID: 22010642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
    Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
    Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT.
    Kassi E; Dalamaga M; Hroussalas G; Kazanis K; Merantzi G; Zachari A; Giamarellos-Bourboulis EJ; Dionyssiou-Asteriou A
    Maturitas; 2010 Sep; 67(1):72-7. PubMed ID: 20570453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: The FIESTA study.
    Peng F; Hu D; Lin X; Chen G; Liang B; Chen Y; Li C; Zhang H; Xia Y; Lin J; Zheng X; Niu W
    Cancer Epidemiol; 2018 Feb; 52():148-157. PubMed ID: 29324354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Resistance in Obese Children: What Can Metabolomics and Adipokine Modelling Contribute?
    Rupérez FJ; Martos-Moreno GÁ; Chamoso-Sánchez D; Barbas C; Argente J
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33137934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between insulin resistance and the development of cardiovascular disease.
    Ormazabal V; Nair S; Elfeky O; Aguayo C; Salomon C; Zuñiga FA
    Cardiovasc Diabetol; 2018 Aug; 17(1):122. PubMed ID: 30170598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: a novel high-risk state for colorectal cancer.
    Ishino K; Mutoh M; Totsuka Y; Nakagama H
    Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fatness, related biomarkers and cancer risk: an epidemiological perspective.
    Nimptsch K; Pischon T
    Horm Mol Biol Clin Investig; 2015 May; 22(2):39-51. PubMed ID: 25781710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.